Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries
about
Cost-effectiveness of dapagliflozin (Forxiga®) added to metformin compared with sulfonylurea added to metformin in type 2 diabetes in the Nordic countries
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Cost-effectiveness of dapaglif ...... abetes in the Nordic countries
@en
type
label
Cost-effectiveness of dapaglif ...... abetes in the Nordic countries
@en
prefLabel
Cost-effectiveness of dapaglif ...... abetes in the Nordic countries
@en
P2093
P1476
Cost-effectiveness of dapaglif ...... abetes in the Nordic countries
@en
P2093
Klas Bergenheim
Mattias Ekman
Ola Granström
Phil McEwan
Ugne Sabale
P356
10.1016/J.PCD.2014.04.007
P577
2014-05-17T00:00:00Z